Abstract. Inheritance of a single copy of the apolipoprotein E (APOE) 4 allele increases risk of Alzheimer's disease (AD) by 3-4-fold, with homozygosity associated with a 12-16-fold increase in risk, relative to 3 allele homozygosity. There is a decreased risk associated with the APOE 2 allele. The pathological consequence of APOE genotype has led to intense efforts to understand the mechanistic basis of the interplay between APOE status and loss of synapses. Numerous 4 allele-related associations have been reported with the potential relevance of these associations to the pathogenesis of AD unknown at this time. In primarily young subjects, we have reviewed a representative body of literature on 4 allele-associations related to the following: cardiovascular responses; impacts on reproduction and fetal development; co-morbidities; resistance to infectious disease; responses to head injury; biochemical differences possibly related to neural stress; and brain structure-function differences. In addition, the literature on the association between the 4 allele and cognitive performance has been reviewed comprehensively. The weight-of-the-evidence supports the hypothesis that possession of the ancestral 4 allele in youth is associated with improved fitness during fetal development, infancy, and youth relative to the more recently appearing 3 allele, at the expense of decreased fitness in old age, which is substantially improved by the 3 allele. However, possession of the 4 allele is also associated with higher levels of synaptic macromolecular turnover, which likely stresses basic cellular neuroplasticity mechanisms. Clinical trials of potential AD therapeutics should consider APOE status as an enrollment criterion.
INTRODUCTION
Alzheimer's disease (AD) is a pathological condition adversely affecting the brain. AD has a large genetic component. The neuropathology is characterized by the presence of neurofibrillary tangles (NFTs) and neuritic plaques [1, 2] . The modern 886
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and microtubule associated protein-tau pathology rather than senile plaque and cerebral A␤ pathology [4] , consistent with the earlier findings of Blessed et al. [2] .
Dementia is a condition involving impairment of cognitive function, which has deteriorated from a prior higher level, and causes social impairment. There are a few types of dementia, mostly frontotemporal (rare) and temporal-parietal (common). Patients with temporal-parietal dementia subdivide into approximately one third with pure AD, one third not AD, and one third being mixed, with the prevalence of mixed cases increasing with age. This progression of AD (NF/NFT/tau pathology) is clearly reflected by both altered cerebral blood flow [5] and cerebral metabolism [6, 7] , as well as by PET tracers targeting tau [8, 9] , with characteristic regional and stage-specific variations [9] . These changes in the brain are closely related to the impairments of memory function that are so typical of the dementia associated with AD and its progression [10, 11] . This pattern has strongly suggested that AD pathology selectively attacks those neuroplastic brain systems which perform the functions of episodic memory [12, 13] . The neuritic plaques and A␤ are consistent components of AD pathology [14] , which is the predominant cause of dementia. However, the distribution pattern of A␤ pathology, which is found at least as early and diffusely in the neocortex as the tau pathology, is found first in most regions of the neocortex [15] but is generally not or much less related to cognitive changes than the tau pathology [16] [17] [18] . With a slowly progressing condition, mild cognitive impairment is a transition from normal cognition that precedes dementia, and is very poorly described [19] .
Previously, we hypothesized that apolipoprotein E (APOE) 4 allele-associated AD risk is consistent with increased lifetime exposure to a neurotoxic process [20] . Specifically, if the hippocampal neurons of two individuals possess the same susceptibility to an endogenous or exogenous stress factor, the neurons with the highest turnover of proteins, lipids, and other macromolecules might experience a larger integrated dose of detriment. Small differences in pharmacokinetic effects might be amplified by the extremely long pre-symptomatic phase of AD, i.e., average age of presentation for a homozygous 4 is about 68 years of age [20] . Studies conducted across the age spectrum from infancy through senescence have suggested that APOE 4-positive status is associated with increased brain activity and macromolecule turnover in young healthy individuals, with the reverse extant in elderly subjects. In the current study, we extend our analysis from the limited number of studies examined in Smith and Ashford [20] and attempt herein to comprehensively examine the literature on reported associations between clinical conditions, cognitive performance, and presence or absence of the 4 allele in otherwise healthy young subjects.
The literature on associations between 4 status in otherwise healthy young subjects falls into several categories including: cardiovascular responses ( Table 1) ; reproduction and development (Table 2) ; co-morbidities (Table 3) ; resistance to infectious disease (Table 4) ; responses to head injury (Table 5) ; biochemical differences possibly related to neural stress (Table 6 ); brain structure-function (Table 7) ; and mental performance ( Table 8) . Possession of the 4 allele is a strong risk factor for development of AD in the elderly, and all individuals possessing the 4 allele are increasingly likely to develop AD the older they live, relative to those without this allele. An understanding of the clinical conditions and cognitive performance characteristics idiosyncratic to healthy young persons who possess the 4 allele might assist in the complex task of disentangling the relative contributions of genetics and lifestyle that appear to play a role in how and when a given individual develops AD [21] .
The mechanism through which inheritance of an allele of a protein associated with cholesterol metabolism, i.e., 4, exerts an increased risk for the development of AD later in life is not understood. One current hypothesis emphasizes that vulnerability to AD is based on the very high rate of formation and removal of synapses in the brain. In healthy individuals, the number of synapses formed and actively removed is estimated to be one trillion per day, presumably associated with constant learning and establishment of new memories. The amyloid-beta protein precursor (A␤PP) plays a central role in this aspect of neuroplasticity [13] . A considerable amount of evidence has related A␤PP to AD [22] , including a relationship between its A␤ product and APOE genotype [23] . A␤PP can be cleaved either by the ␣-secretase, which leads to increased local synapse production and prevents formation of the synaptotoxic A␤ molecule or by the ␤-secretase, followed by ␥-secretase, which leads to the removal of the affected synapse [22] . The control of the delicate balance between synapse creation and destruction is critical for learning and involves numerous mechanisms, with a positive neuronal action culminating in activation of the ␣-secretase, while activation failure leads Table 1 Cardiovascular responses in young apolipoprotein Mixed APOE phenotype determines serum cholesterol in infants during both high-cholesterol breast feeding and low-cholesterol formula feeding In infants fed high-fat, high-cholesterol human milk, the total and LDL-cholesterol concentrations and the LDL apoB concentration of those with the APOE phenotype 4/4 or 3/4 rose faster and to higher levels than in other infants Kallio et al. [46] Moderate (Continued) Low AD, Alzheimer's disease; APOE, apolipoprotein E; DHA, docosahexaenoic acid; PET, positron emission tomography. Table 7 Brain structure and brain function differences in young apolipoprotein Reiman et al. [109] Low AD, Alzheimer's disease; APOE, apolipoprotein E; BDNF, brain-derived neurotrophic factor; BOLD, blood-oxygenation-level-dependent; fMRI, functional magnetic resonance imaging; HIV-1, human immunodeficiency virus-1; MRI, magnetic resonance imaging; PET, positron emission tomography. to the default action, ␤-secretase cleavage, then ␥-secretase cleavage of the A␤PP, with the end-products being fatal to that synapse. Note that the ␥-secretase appears to act only on the ␤-secretase product and not on the ␣-secretase product, producing both the A␤ and an A␤PP intracellular domain (AICD) [24] . The AICD protein, acting intracellularly, leads to hyperphosphorylation of the critical structural protein of neuronal processes, microtubule associated protein tau [25] . The hyperphosphorylated tau appears to disrupt the normal flow in neuronal processes, leading to amputation [26] . The initial memory impairment of AD is likely due to the failure of the process for establishing new memory, while the dementia appears to develop when synaptic slaughter destroys large numbers of synapses [27] , and loss of synapses is the factor most closely associated with the late progression of dementia [28] . Cholesterol metabolism, transport and processing might play a role in this process by affecting the composition of the neuronal synaptic membrane thereby altering its thickness. The extracellular region of A␤PP is much longer than the intracellular region. Small differences in the availability of enzymatic cleavage sites influenced by membrane thickness might have profound effects on the ultimate production of A␤PP sub-fragments [29, 30] .
IMPORTANCE OF THE APOE GENOTYPE
The APOE genotype accounts for the vast majority of AD risk [31, 32] . There are three common alleles of the APOE gene, i.e., APOE 2, APOE 3, and APOE 4 [33] . In the general US population, the 4 allele prevalence is approximately 13% [34] , constituted by about 2% being 4 homozygous (2% of the US population) and 11% being heterozygous (22% of the US population). Possession of one 4 allele increases the risk of developing AD by 3 to 4-fold, and possession of two 4 alleles increases risk by 15-fold, as compared with the 3/3 genotype, with a large part of the variation being related to substantially early age of onset, and over 60% of patients with non-familial AD carry the 4 allele [35, 36] .
This profound difference in AD risk results from only minor changes in the structure of the APOE molecule. The three isoforms of APOE differ in amino acid sequence at only chain positions 112 and 158: the APOE 2 allele has cysteine at both positions; the APOE 4 allele has arginine at both positions; and the APOE 3 allele has cysteine at position 112 and arginine at 158 [37] . These small changes in amino acid sequence alter the biological activity of the APOE proteins in multiple ways, one of which is increased liver catabolism of the APOE 4 lipoprotein as compared with the APOE 3 lipoprotein [38, 39] .
The strong positive association between possession of the 4 allele and the development of late-onset AD has stimulated extensive investigation on young, healthy subjects differing in APOE allele status. Numerous 4 allele-related associations have been reported in a series of epidemiological and clinical investigations on a variety of conditions, with the potential relevance of these associations to the pathogenesis of AD poorly understood at this time. Over the last several decades, numerous and elaborate interactions have been demonstrated between the nervous, immune, and endocrine systems [40] . This sophisticated system of sometimes centrally mediated biochemical cross-talk opens the possibility that an association between possession of the 4 allele and a particular clinical characteristic, condition, susceptibility or outcome might provide mechanistic information as to why allelic variation in a cholesterol metabolism gene is so strongly associated with the loss of synapses in the brain.
In primarily young subjects, we have attempted to review a representative body of literature on 4 allele-associations related to the following: cardiovascular responses; impacts on reproduction and fetal development; co-morbidities; resistance to infectious disease; responses to head injury; biochemical differences possibly related to neural stress; and brain structure-function differences. In addition, the literature on the association between the 4 allele and cognitive performance has been reviewed comprehensively. In each summary table, the ethnic composition, age, clinical diagnosis, and number of 4 carriers of the cohort studied are included.
LITERATURE SEARCH STRATEGY
Using Google and PubMed of the National Library of Medicine, the search terms apolipoprotein E or 4 allele were cross-matched against the terms: infant, youth, child, children, adolescent, or young. This initial search gathered a large number of potentially relevant citations that were categorized by clinical condition including cardiovascular responses; reproduction and development; co-morbidities; resistance to infectious disease; responses to head injury; biochemical differences possibly related to neural stress; brain structure-function; and mental performance. Each citation was physically collected, and the reference sections were manually checked for additional relevant citations until no further citations were found. No papers on the relevant topics were excluded. A few studies on middle age subjects not yet presenting with mild cognitive impairment were included with the aberrant age ranges clearly marked in the tables. The studies in the tables were not amenable to meta-analysis as the protocols were too heterogeneous. There were four referenced articles ( [15, 47, 53, 130] ) that included a meta-analysis. Some of the individual papers in the meta-analyses were also separately included in the review because the details in the individual papers were important.
METHOD FOR GRADING QUALITY OF EVIDENCE
As noted previously, the literature on associations between 4 status in otherwise healthy young subjects can be subdivided into several categories including: cardiovascular responses (Table 1) ; reproduction and development (Table 2) ; co-morbidities (Table 3) ; resistance to infectious disease (Table 4) ; responses to head injury (Table 5) ; biochemical differences possibly related to neural stress (Table 6 ); brain structure-function (Table 7) ; and mental performance (Table 8) . Each table contains seven headings including sequentially: Subject/Age; Sample Size; Sex; Study Scope; Major Finding; Citation; and Quality of Evidence. The first six headings summarize the study characteristics, its results, and citation. The seventh heading provides the reader an estimate of the quality of evidence in the study based on a recognized evidence-based rating system.
A system developed by the Grading of Recommendations Assessment, Development and Evaluation Working Group (GRADE) for ranking the quality of evidence and the strength of recommendations of scientific literature and clinical practice guideline was applied to rate the studies found in Tables 1-8 [41] . The method described by Adkins et al. [41] was used to estimate the degree of confidence that can be placed on the evidence from research and clinical studies. The studies in the tables of this review represent a wide range of data (high to low) based on quality of evidence regarding main outcomes. The quality of evidence for each study was evaluated based on the following criteria.
• Study design (e.g., observational versus randomized trials); • Study quality (i.e., detailed study methods and execution); • Consistency (similarity of estimates of effects across like studies); and • Directness (i.e., the extent to which the subjects, interventions, and outcomes measures are similar to those of interest).
The following definitions from the GRADE Working Group were used in grading the quality of the evidence based on the criteria above [41] :
• High = Further research is very unlikely to change our confidence in the estimate of effect.
• Moderate = Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
• Low = Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
• Very low = Any estimate of effect is very uncertain.
It should be recognized that the ranking system is based on the quality of the evidence and not on the quality of the research, as all of the cited literature in this review was peer-reviewed.
CARDIOVASCULAR RESPONSES IN YOUNG APOLIPOPROTEIN 4 CARRIERS (TABLE 1)
The relationship between APOE allele type and cardiovascular risk factors and responses has been extensively studied. In a large study on Finnish boys and girls (Table 1) , ages 3, 6, 9, 12, 15, and 18, including 28 2/4 carriers, 483 3/4 carriers, and 50 4/4 carriers, the concentrations of serum total cholesterol, low density lipoprotein cholesterol, and apolipoprotein B increased with APOE phenotype in the order of 2/2, 3/2, 4/2, 3/3, 4/3, and 4/4 [42] . In a follow-up study on Finnish male and female newborns and 3-year-old children including five 2/4, 147 3/4, and eight 4/4 carriers, the concentrations of serum total cholesterol and LDL cholesterol increased with APOE phenotype in the order of 3/2, 3/3, 4/3, and 4/4, in both males and females (p < 0.001) in the 3-yearolds [43] . Another large study in 7-and 13-month-old Finnish infants included 36 4/4 and 209 3/4 carriers and reported that triglyceride concentrations were higher in infants with APOE 4/4 or 3/4 than in those with APOE 3/3 (p-value for difference 0.01 and 0.009, respectively) [44] . A smaller follow-up study was conducted on healthy 13-monthold Finnish children and reported that 16 APOE 4 children had 30% to 50% higher cholesterol-adjusted campesterol and sitosterol concentrations in serum than 20 APOE 3/3 children (p = 0.002 and p = 0.02, respectively) [45] . In 44 4 carrier Finnish infants, fed high-fat, high-cholesterol human milk, the total and LDL-cholesterol concentrations and the LDL APOB concentration of those with the APOE phenotype 4/4 or 3/4 rose faster and to higher levels than in other infants [46] . In a large study on 16-year-old Finnish boys and girls including 28 2/4 carriers, 470 3/4 carriers, and 49 4/4 carriers, physical exercise did not affect LDL cholesterol, total cholesterol, or HDL/total cholesterol in APOE 4 carriers [47] . In 1999, a study on Caucasian males in Perth, Australia, including eight pairs of 3/3 and 4/4 subjects matched for age and serum lipid levels, average age for the 3/3 = 45 and 4/4 = 42, suggested that inheritance of APOE 4 is associated with an increased affinity of VLDL particles for LDL receptors on hepatocytes [48] .
Cardiovascular endpoints in addition to blood lipid levels have also been examined. 3/2 or 3/3 carriers showed marginally significantly greater heart rate reactivity and significantly greater task levels of heart rate and heart rate variability during mental stress than 4/2, 4/3, or 4/4 carriers among 28 healthy 16-year-old Finnish boys. The number of 4 carriers in this study was limited at only 11 [49] . Ellis et al. [50] studied 8-year-old children from the Tasmanian Infant Health Survey including 75 4 carriers and found that the 4 carriers had a lower body mass index and the effect was more evident among the less fit. In addition, Yu et al. [51] studied young adult Chinese men and women with an approximate mean age = 32; 3/4 (N = 60), 4/4 (N = 13). These authors found that VO 2max after exercise training increased significantly higher in carriers of 3/4 in males (OR = 0.60, 95% CI = 0.09-1.11; p = 0.02) and females (OR = 0.62, 95% CI = 0.09-1.15; p = 0.02). In summary, as compared with 3 carriers, young subjects possessing one or more 4 alleles show significant differences in total serum cholesterol, LDL, triglycerides, heart rate variability during mental stress, and VO 2max . The directionality of the reported 4-associated lipid profiles is consistent with an increased risk of atherosclerosis later in life.
Possible relationship of 4-related cardiovascular responses and AD
As noted in the Introduction, cholesterol metabolism might play a role in slightly altering the thickness of the synaptic membrane. Synaptic membrane thickness could potentially affect the location of the cleavage site for ␥-secretase [29, 30] A␤PP sub-fragments possibly being more potent for synaptic remodeling and learning, including playing a role in tau phosphorylation for synapse retraction, could also possess increased pathogenicity for the elderly, leading to tau hyperphosphorylation, the creation of paired-helical filaments, neuropil threads, and NFTs, with amputations of neuritic processes and massive destruction of synapses.
REPRODUCTION AND DEVELOPMENT IN APOLIPOPROTEIN 4 CARRIERS (TABLE 2)
A limited number of studies have examined potential associations between APOE 4 carrier status and fertility. In 2017, van Exel et al. [52] studied 100 women with a history of at least two firsttrimester recurrent miscarriages in Tabriz, Iran, and 100 healthy women with at least two successful pregnancies and no miscarriages. This study incorporated 31 4 carriers and showed that APOE 4 was associated with higher fertility in women exposed to high pathogen levels. In 2004, Corbo et al. [53] reported similar results in a population of Afro-Ecuadorian and Cayapa Indian women, average age 39; 4 carriers (3/4 = 16; 4/4 = 6; 4/2 = 5). These authors reported that the 3/4 genotype frequency (0.50) in the African-Ecuadorian women with 9-17 children was about three times that of the women with 0-8 children (0.14) (p = 0.02). In contrast with these reportedly positive effects on fertility in populations without access to birth control methods, Gerdes et al. [54] studied a cohort of 40-year-old married men residing in Aarhus Denmark; 4 carriers (3/4 = 93; 4/4 = 12; 4/2 = 9) and found that on average, men with the 3/3 genotype (n = 212) had 1.93 children, men with the 3/4 or 2/2 genotypes (n = 53) had 1.66 children. The potential confounding effects of the widespread availability of birth control methods in Denmark and the low average number of children per couple questions the clinical relevancy of these findings as per the association of the 4 allele and fertility.
Several studies have investigated the possible relationship between APOE 4 carrier status and occurrence of fetal miscarriages. A single study has reported a protective effect of the 4 allele [55] . Some studies do not report an association between 4 status and fetal loss [56] [57] [58] . At least five studies and one meta-analysis report a positive association between possession of the 4 allele and fetal loss [59] [60] [61] [62] [63] [64] [65] . Several additional studies have examined the association between 4 carrier status and a variety of pregnancyrelated conditions. Gaynor et al. [66] studied White, Black, and Hispanic neonates and infants; 4 carriers (N = 87) and reported that the APOE 2 allele was associated with a lower Psychomotor Development Index (p = 0.038). Pregnant women with the 4 allele displayed an increased risk to develop Pregnancy Induced Hypertension (OR 4.14, p = 0.013) and severe preeclampsia (OR 4.43, p = 0.019) in a group of pregnant Romanian women, average age 28; 4 carriers (N = 46) [67] . Cerebrospinal fluid (CSF) was collected from 107 healthy Japanese subjects (70 males, 37 females) aged 1-86 by Hirayama et al. [68] who showed that the APOE phenotype does not affect the composition or concentration of CSF high density lipoprotein in children. In 2003, Gaynor et al. [69] studied Asian, Black, and White, male and female infants under 6 months undergoing cardiac surgery in Philadelphia; 4 carriers (N = 52) and reported that patients with the 2 allele had approximately a 7-point decrease in the Psychomotor Developmental Index [Bayley Scales of Infant Development] (p = 0.036).
In summary, the most notable findings related to fertility and the 4 allele suggest a protective effect of 4 + status and reproductive potential in populations exposed to high pathogen levels.
Possible relationship between -related reproduction and development and AD
The 4 allele is the ancestral allele to the now more common 3 allele. Protective effects on fertility and reproduction might help explain the original predominance of the 4 allele. The impetus for the conversion from 4 to 3 predominance is currently not understood.
CO-MORBIDITIES IN YOUNG APOLIPOPROTEIN 4 CARRIERS (TABLE 3)
A number of epidemiology studies have reported co-morbidities associated with possession of different APOE alleles (Table 1) . Co-morbidities represent an important area of study as co-linearity in prevalence between clinical conditions of known etiology with clinical conditions whose current etiology is unknown (e.g., AD) might provide clues related to causation. A meta-analysis of 28 studies on schizophrenia reported a significant protective effect of 3 in an Asian population [70] . Another meta-analysis found a significant decrease in risk associated with each copy of 4 in all age-related macular degeneration sub-phenotypes [71] . A dermatology clinic in Spain reported that APOE 4 carriers were significantly more frequent in patients with severe psoriasis compared to controls (p = 0.003) and to non-severe psoriasis (p = 0.017). Infants with hypoxic-ischemic encephalopathy did not show an association with APOE allele type [72] . In contrast, the percentage of children with at least one 4 allele was significantly lower in non-Sudden infant death syndrome (SIDS) compared to SIDS (p = 0.016) in a study of infants from Scotland. Several studies have examined the potential relationship between APOE allele type and cerebral palsy. In children seen in Brasilia, Brazil, of whom 139 were 4 carriers, the presence of the 2 allele raised the probability of having cerebral palsy (OR 3.2; 95% CI 1.27-8.27) while the APOE 4 allele was not significantly different among groups [73] . An earlier smaller study on Brazilian children that included only 13 4 carriers, reported a positive association between the 4 allele and cerebral palsy [74] , as did a study on children from Chicago that included 25 4 carriers [75] .
Possible relationship between 4-related co-morbidities and AD
The mechanism by which possession of the 4 allele exerts its increase risk of AD is currently unknown. Concomitantly, the mechanistic relationships between co-morbid clinical conditions and the 4 allele, and risk of AD, are also not understood. As mechanistic relationships on AD causation are elucidated in the future, 4-related co-morbidities might provide additional mechanistic insights.
RESISTANCE TO INFECTIOUS DISEASE IN APOLIPOPROTEIN 4 CARRIERS (TABLE 4)
The potential relationship between resistance to infectious diseases and APOE allele status represents an important area of investigation as this environmental stressor can exert significant evolutionary pressures. The relationship between hepatitis C infection and APOE carrier status has been examined in several studies. Mueller et al. [76] enrolled 205 4 carriers in two combined cohorts selected from patients from Charite Berlin and the University of Leipzig diagnosed with either chronic or self-limited hepatitis C virus infection. The average age of the patients was 48.7. These authors found that APOE 4 alleles were underrepresented in chronically hepatitis C-infected patients (10.2%) compared to 13% in healthy controls (p = 0.001).
Male and female Caucasian Italian patients with chronic hepatitis C, median age = 41; 2/4 carriers (N = 3), 3/4 carriers (N = 21), 4/4 carriers (N = 1) were studied by Fabris et al. [77] . They reported that patients not carrying an 3 allele, as well as carriers of a single 3 allele with serum cholesterol concentration >190 mg/dL were more likely to have a favorable outcome regarding fibrosis progression with chronic hepatitis C. In an earlier study, Fabris et al. [78] investigated Italian male and female patients who underwent a cadaveric orthotopic liver transplantation, median age 55; 4 carriers (N = 34). Their results showed that possession of an APOE 4 allele to be associated with low fibrosis progression in recurrent hepatitis C infection, and with an idiosyncratic APOE-associated lipid profile. Price et al. [79] found that the APOE 2 and APOE 4 alleles were both associated with a reduced likelihood of chronic infection (hepatitis C virus). [80] . These authors found that recipient (but not donor) carriage of at least one 4 allele was associated with improvement in the staging score due exclusively to the contribution given by male recipients. Similarly, Wozniak et al. [81] observed British men and women with hepatitis C viral infection, mean age = 41; 4 carriers (N = 42) and concluded that in chronically hepatitis C virus-infected subjects grouped according to extent of fibrosis, necroinflammation, and total Knodell score, an overrepresentation of the APOE 4 allele was found in those whose livers were mildly affected.
These authors suggested that carriage of an APOE4 4 allele protects against severe liver damage induced by hepatitis C virus.
Although not as extensively studied as hepatitis C infection, the relationship between resistance to malaria and APOE allele status has also been examined in several studies. Fujioka et al. [82] showed that human plasma samples from APOE 4/4 but not APOE 3/3 donors inhibited growth and disrupted morphology of P. falciparum (malaria) in seven APOE 4/4 and six APOE 3/3 donors from Cleveland, OH, USA. Aucan et al. [83] observed Gambian children ages 1-10; 4 carriers (N = 244) and concluded that the APOE 3/4 genotype was found to be more common in children with both cerebral malaria and severe malarial anemia (42.9%) than in controls (24.8%) and mild malaria cases (27.2%). When corrected for the number of clinical groups (4) compared with controls in this study, this finding was not statistically significant. An earlier study on African infants was reported by Wozniak et al. [84] . This group studied infants from Prampram, 50 km east of Accra on the south coast of Ghana; 2/2 carriers (N = 4), 4 carriers (N = 47). Based on small numbers, APOE 2 homozygotes became infected with malaria at an earlier age than those carrying other genotypes.
At least one study on a potential relationship between APOE allele status and risk for development of herpes simplex encephalitis has been conducted in the United Kingdom [85] . These authors examined specimens from the brain or spleen of 14 patients with herpes simplex encephalitis and from the CSF of seven patients with HSV1 in their CSF detected by PCR. Lin et al. [85] concluded that APOE 3 and 4 allele frequencies did not differ significantly between the two groups, and that APOE 2 is a risk factor for herpes simplex encephalitis. In summary, possession of the 4 allele might provide some measure of protection against hepatitis C and malaria.
Possible relationship between 4-related resistance to infectious disease and AD 4 allele-associated resistance to infectious diseases endemic in prehistoric populations is consistent with the ancestral predominance of the 4 allele. Evolutionary pressures or mechanisms that influenced the conversion of human populations from 4 predominance to 3 predominance remain unexplained.
RESPONSES TO HEAD INJURY IN YOUNG APOLIPOPROTEIN 4 CARRIERS (TABLE 5)
Several studies have been conducted on the association between APOE allele frequency and either susceptibility to head injury, or recovery from head injury. In a 2018 study by Terrell et al. [86] on a cohort of male football and male and female soccer players (average age 19.85) from four US southern universities that enrolled 35 4 carriers, IL-6R CC was associated with a three times greater concussion risk and APOE 4 with a 40% lower risk. In a similar cohort with 62 4 carriers, Tierney et al. [87] found no significant association between carrying the 4 allele and history of concussion. However, Tierney et al. [87] stated that they assessed the medical history via researcher-assisted paper and pencil assessment, attempting to indicate the athlete's concussion history. Collegiate student athletes from the University of Toronto, average age 20.5, with 79 4 carriers were studied by Kristman et al. [88] with a small statistically significant positive association reported as stated by the authors of an unadjusted hazard ratio for concussion in the APOE 4 carriers of 1.18 (95% CI: 0.52, 2.69) compared to non-carriers. Adjusting for sex, weight, height, and team type resulted in an only slightly lower hazard ratio of 1.06 (95% CI: 0.41, 2.72), indicating little effect from confounding factors. A somewhat larger study that relied upon self-reported concussion history over the previous eight years was conducted by Terrell et al. [89] on Black and White, male and female, college athletes from 23 schools, average age 19.7; 3/4 (N = 225), 4/4 (N = 20). Terrell et al. [89] summarized their results as showing no substantial evidence of an association between a history of concussion and APOE genotypes and haplotypes. However, the authors also noted that the cell sizes for some of the APOE genotypes were so small that meaningful analysis was not possible. Also, compared to those with the APOE 3/3 genotype, those with the 2/3 genotype were at a 60% higher risk for concussion, but the results were not statistically significant (OR, 1.6; 95% CI, 0.5 to 4.8). In summary, the association between possession of the APOE 4 allele and risk of concussion is unclear at this time due to methodological limitations in determination of concussion history and limited sample sizes.
Han et al. [90] conducted a study on active duty military personnel with a recent history of mild to moderate traumatic brain injury, average age 22.6; 4 carriers (N = 16). Their analysis showed comparable performances on most neuropsychological measures and better performances by 4 carriers on select measures of attention, executive functioning and episodic memory encoding. Merritt et al. [91] reported data on 53 veterans with a history of mild traumatic brain injury and 46 military controls and found that traumatic brain injury 4 carriers had relative impairments in memory function and speed of processing but not on executive function relative to traumatic brain injury-affected veterans without an 4 allele. However, there was no 4-related difference among the non-traumatic brain injury military controls.
In a relatively large study (4 carriers N = 324) enrolling consecutive head injury admissions (men and women) to a regional neurosurgical unit in West Scotland, average age 35, Teasdale et al. [92] found no overall association between APOE genotype and outcome. Thirty-six percent of APOE 4 carriers had an unfavorable outcome compared with 33% of noncarriers of APOE 4. This relatively large study was a follow-up to a smaller study conducted by Teasdale et al. in 1997 [93] on only 30 4 carriers. Another small study on 16 3/4 subjects recruited from a Canadian traumatic brain injury clinic who experienced mild to moderate traumatic brain injury, mean age 33, was conducted by Chamelian et al. [94] . These authors reported no association between the presence of the APOE 4 allele and poor outcome across all measures. In 2005, Blackman et al. [95] reviewed the childhood literature on APOE and brain injury up through 2005 and concluded that results from the limited studies in children were contrary to the adult experience with 4 seeming to confer protection for the brain whereas 2 posed a risk. Further larger studies are needed to definitively determine the role of APOE status on recovery from brain injury in young subjects.
Possible relationship between 4-related responses to head injury and AD
To date, a definitive relationship between 4 status and recovery from head injury has not been established. If 4 possession was established as associated with poor recovery from head injury, poor recovery could be consistent with an 4-associated increase in neural stress. Damage from accumulated neural stress might be a contributing factor to AD.
BIOCHEMICAL DIFFERENCES POSSIBLY RELATED TO NEURAL STRESS IN APOLIPOPROTEIN 4 CARRIERS (TABLE 6)
The strongest direct evidence that some of the macromolecular components comprising the synapses of 4 carriers might be turned over at a higher rate than comparable macromolecular synaptic components in non-4 carriers has been provided by Yassine et al. [96] . This group studied 22 middleaged healthy adults (mean age 35 years, range 19-65 years) and found that k*, the mean global gray matter DHA incorporation coefficient, was significantly higher (16%) among 4 carriers (n = 9) than among non-carriers (n = 13, p = 0.046). Also in 2017, the same group [13] reviewed original articles, systematic reviews, and meta-analyses of omega-3 studies in AD that were published before August 20, 2016 and concluded that while randomized clinical trials of omega-3 in symptomatic AD reported negative findings, several observational and clinical trials of omega-3 in the pre-dementia stage of AD suggest that omega-3 supplementation might slow early memory decline in 4 carriers. Tambini et al. [97] conducted an in vitro experiment whose results are consistent with the increased lipid metabolism observed by Yassine et al. [96] . Using an astrocyte-conditioned media model, this group measured the synthesis of phospholipids and cholesteryl esters and reported a significant increase in cells treated with APOE 4-containing astrocyte-conditioned media as compared to those treated with APOE 3-containing-astrocyteconditioned media.
Dose et al. [98] conducted a mini-review of APOE genotype and stress responses. From their analysis of the evidence on APOE isoform-dependent oxidative stress and mitochondrial function these authors concluded that APOE4 is associated with an increased stress response. Ramassamy et al. [99] conducted a brain tissue study whose results are consistent with the observations of Dose et al. [98] . They obtained human brain tissue from the Douglas Hospital Research Centre Brain Bank, Canada, average age 75-79; 4 carriers (N = 18). Among 4 carriers with AD, the levels of thiobarbituric acid-reactive substances were found to be higher among 4 carriers while the APOE protein concentrations were lower.
At least one small study has examined the potential association between vitamin D and APOE allele status [100] . In a sub-group of 93 subjects from a general population sample of 699 subjects (age of subjects unknown), multivariate adjusted modeling showed a positive association (p = 0.072) of the APOE 4 allele with 25(OH)D [vitamin D] levels. Another small study was conducted in 2012 by Ringman et al. [101] wherein thirty-three subjects were studied including six 2/3, six 3/4, and 21 3/4 allele combinations. Plasma levels of APOE and superoxide dismutase 1 were lowest in 4 carriers, intermediate in 3 carriers, and highest in the 2 carriers. In contrast, multiple plasma interleukins were highest in 4 carriers and demonstrated significant negative correlations with age. Larger studies similar to those conducted by Yassine et al. would be helpful in clarifying the association of neural stress/macromolecular turnover rate with allele subtype.
Possible relationship between 4-related biochemical changes related to neural stress and AD
If the hippocampal neurons of two individuals possess the same susceptibility to an endogenous or exogenous stress factor, the neurons with the highest turnover of proteins, lipids, and other macromolecules might experience a larger integrated dose of detriment.
BRAIN STRUCTURE-FUNCTION DIFFERENCES IN YOUNG APOLIPOPROTEIN 4 CARRIERS (TABLE 7)

Studies on brain structure
Several studies have reported subtle differences in brain structure in association with APOE allele status. Stening et al. [102] These authors reported the emergence of two different patterns. The first pattern showed that specific structural covariance of the anterior hippocampus and posterior hippocampus in all other groups co-varied with frontal, parietal and cerebellar areas. The second pattern displayed an opposite structural covariance of the posterior hippocampus in 4 carriers and the anterior hippocampus of 4 non-carriers co-varying with motor areas and the middle frontal gyrus. Given the small subject numbers, and uncertainty of the clinical significance of these differences in anatomic ratios, the relevance to the development of AD pathology and the later appearance of dementia is unknown.
A young group (average age 21) and a mid-age group (average age 50), of right-handed males and females with 21 4 carriers in the young group and 17 in the mid-age group (N = 17) was investigated by Dowell et al. [103] . They found no detectable genotype-dependent differences in hippocampal volume for either the young or mid-aged adults. Also, the cuneus appeared to be an important locus for genotype differences with greater functional connectivity among young 3/3 individuals and greater white matter volume in young 4 + individuals. These authors also reported subtle cortical thickness measures in the parahippocampus in the young 4 + individuals positively correlated with performance in a memory task. This 2016 study was a followup to an earlier study published by Dowell et al. [104] . The earlier 2013 study enrolled 93 healthy young participants (age, 20; range 18-30; 64 women, 29 men), right-handed Caucasian undergraduates at the University of Sussex. The authors summarized their results using voxel-based morphometry of highresolution structural MR images as identifying a higher white matter volume ratio in 4 relative to homozygous 3 carriers.
In 2011, Alexopoulos et al. [105] reported that healthy young APOE 4 carriers have statistically smaller hippocampal volumes than APOE 2 carriers. No differences were detected between the two groups in memory performance. The study population in Alexopoulos et al. [105] consisted of 33 healthy young German students, average age 24, carrying either the APOE 2 or the 4 allele: 2/3 (N = 15), 2/2 (N = 2), 3/4 (N = 12), 4/4 (N = 4).
In a study incorporating 20 4 carriers, Sidiropoulos et al. [106] found no correlations between brain derived neurotrophic factor (BDNF) or APOE genotype and hemispheric or lateral ventricular volumes. The study measured the hemispheric and lateral ventricular volumes of 144 healthy individuals, aged 19-35 years, using high resolution magnetic resonance imaging (MRI) and data were correlated with BDNF and APOE genotypes.
Studies on brain function
In addition to imaging studies that have been conducted on brain morphology, several studies have examined brain function in association with 4 carrier status. In 2009, Filippini et al. [107] conducted resting functional MRI (fMRI) on 18 young healthy male and female APOE 4 carriers and 18 matched noncarriers (age range [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] . These authors observed increased default mode network (involving retrosplenial, medial temporal, and medial-prefrontal cortical areas) co-activation in 4 carriers relative to noncarriers. Also, the encoding task produced greater hippocampal activation in 4 carriers relative to noncarriers. Scarmeas et al. [108] studied 20 healthy young adults (age 19 to 28 years; four 4 carriers and 16 non-4 carriers) during a non-verbal memory task. Using PET imaging, brain regions were identified where 4 carriers showed significantly lower or higher activation than non-carriers. Young 4 carriers had abnormally low rates of glucose metabolism bilaterally in the posterior cingulate, parietal, temporal, and prefrontal cortex in 139 20-39 age range, normal male and female volunteers, average age 31; 4 carriers (N = 12) [109] . The small subject numbers, high cost and labor intensity of imaging modalities, and heterogeneity of protocol design renders definitive interpretation of these structure and function studies problematic. However, lower brain metabolism in association with task performance can reasonably be assumed to represent a lower level of neural stress per unit time. Perhaps protocol design of imaging studies on metabolic demand should consider studying the brain areas recruited for tasks showing the greatest performance differential between 3 and 4 carriers.
Evans et al. [110] examined students from the University of Sussex, average age = 20.92; 4 carriers (N = 28). In 4 carriers only, these authors found that subsequently remembered words were linked to increased hippocampal activity. Additionally, Evans et al. reported that genotype status modulated hippocampal activity in the recognition phase [110] . Carriers of 4 did not show the conventional pattern of greater hippocampal activity to novel words.
Dennis et al. [111] enrolled 24 healthy young adults, 12 carriers and 12 non-carriers of the APOE 4 allele, and scanned them in a subsequent memory paradigm, using event-related fMRI. These authors reported that the APOE 4 allele carriers exhibited greater bilateral medial temporal lobe activity relative to the non-carriers to accomplish the same encoding task. In addition, 4 carriers demonstrated greater functional connectivity of encoding success activity-related medial temporal lobe activity with the posterior cingulate and other peri-limbic regions, with overall connectivity reductions found across anterior and posterior cortices.
Possible relationship between 4-related brain structure and brain function and AD
Preliminary imaging data suggest that certain brain regions related to memory processes might contain fewer neurons in carriers of the 4 allele than in noncarriers. Studies suggest the presence of increased mental performance in young healthy subjects who possess the 4 allele. Increased mental performance elicited from a reduced population of neurons might be exposing the young healthy 4 + brain to neural stress. The process of synaptic formation and normal homeostatic synaptic loss might be adversely impacted by long-term neural stress.
MENTAL PERFORMANCE IN YOUNG APOLIPOPROTEIN 4 CARRIERS (TABLE 8)
At least 32 studies or meta-analyses have examined mental performance in young APOE 4 carriers. No effect of the APOE allele was reported in six studies [112] [113] [114] [115] [116] [117] . All six of the study populations reporting no effect were Caucasian and lived in the United States, United Kingdom, or Western Europe. A single study [118] on only 33 4 carriers reported inferior performance associated with possession of 4. Significant differences were found on the Rey-Osterrieth Complex Figure Test , with 2-positive children scoring 29.2% relative to 3/3 at 8.9% and 4-positive children at 6.1% (p = 0.12).
Three studies reported improved performance in spatial tasks in 4 carriers [102, 119, 120] . A large British study (3/4 = 542, 4/4 = 43) showed faster reaction times in association with the 4 allele [121] . In a series of studies, Oria et al. [122] [123] [124] have shown that possession of the 4 allele protects against long-term cognitive deficits associated with severe diarrhea in Brazilian shanty-town children. In young Finnish men and women (mean age = 28), 4 carriers (N = 20), 4 + status was associated with good performance in mental arithmetic and the association was dependent on LDL cholesterol level [125] .
Two studies have reported a higher IQ in 4 carriers. In a large British study [126] , there was a consistent pattern that 2/2 and 4/4 girls had higher IQ scores (from 3 to 7 points) compared with 3/3 girls. A small study (31 4 carriers) on Han Chinese female nursing students showed a modest increase in performance IQ and N100 amplitude for 4 carriers (p = 0.038 and 0.068, respectively) [127] . Using the same cohort of nursing students reported in Yu et al. [127] , 4 + status did not affect tridimensional personality questionnaire scores [128] . In contrast with the lack of correlation with personality reported in the small cohort of Tsai et al. [128] , a large study on Finnish children, adolescents, and young adults [4/3 (N = 483) and 4/4 (N = 50)] reported that motor activity and even hyperactivity in childhood, and mental vitality in adolescence and young adulthood increased significantly in the order of 2/2, 3/2, 4/2, 3/3, 4/3, and 4/4 [129] . In addition, 4 carriers displayed a wider field of attention in two tasks [130] .
Several studies have reported better performance on memory tasks in young subjects possessing the 4 allele [131] [132] [133] [134] [135] [136] . Comparatively enhanced verbal fluency has also been observed in 4 allele carriers [137, 104] . In a study on 53 infants in Mexico City who were 4 carriers, 4 + status had a 4.4 point higher 24-month Mental Development Index on the Bayley Scale [138] . A small study from the Czech Republic on 23 4 + subjects suggested that early life cognitive advantages might persist through young adulthood as 87% of 4 + carriers reached higher education [139] .
The results from two studies suggest that the cognitive response to particular pharmacologic agents might be affected by APOE 4 status. Twentyseven 4 carriers who were healthy nonsmokers, aged 18-30 recruited from Sussex University demonstrated that the 4 allele confers a cognitive advantage on tasks mediated by the frontal lobes. In addition, young carriers of the 4 allele show larger cognitive benefit from procholinergic nicotinic stimulation [140] . In the second study, poor Brazilian children with below median height (mean age = 8.6), including 37 4 carriers reported that 4 + children receiving glutamine supplementation showed short-term gains in HAZ (height for age Z score), WAZ (weight for age Z score) and WHZ (weight for height Z score) that were correlated with better performance in long-term cognitive testing [141] .
In this review of cognition and APOE allele genotype, our emphasis has been on -related clinical and performance associations in young rather than middle-age subjects. Several recent studies on middle age cohorts might address the issue of transition from 4-associated cognitive advantage to cognitive deficit. In an older cohort with an average age for 4 carriers of 58.0 and non-carriers of 61.4, Caselli et al. [142] sought to determine the age at presentation of 4-related declines in memory. They enrolled 815 subjects: 317 4 carriers, 79 of whom were 4/4 and 238 3/4. The non-carrier group contained 498 subjects. Carriers were followed for a longer period (5.3 versus 4.7 years, p = 0.01), with an equivalent duration of formal education (15.4 years) and proportion of women (69%). Longitudinal decline in memory in 4 carriers began before age 60 and showed greater acceleration than in noncarriers (p = 0.03). There was a possible 4 dose effect (p = 0.008). In 2017, Lancaster et al. published a systematic and meta-analytic review of 36 studies on subjects ranging from 35-60 years old investigating APOE-related differences in cognition in mid-adulthood [143] . The average effect size of 4 status was non-significant across cognitive domains. Sinclair et al. [144] studied 114 participants with the allelic combinations of 3/3 (39 subjects), 3/4 (27 subjects), 4/4 (15 subjects), 3/2 (26 subjects), and 2/2 (7 subjects). The primary outcome was performance on the Rey Auditory Verbal Learning Test (RAVLT). 2 carriers displayed slightly better episodic memory performance (p = 0.016), somewhat improved n-back accuracy and better executive functioning (p = 0.005).
Possible relationship between 4-related increases in mental performance and AD
The observation of increased mental performance in young healthy carriers of the 4 allele is consistent with the observation of increased brain lipid metabolism. Taken together, these observations suggest that macromolecular turnover rates related to synapse formation and loss might be elevated in these young 4 carriers. It is possible that a higher rate of synaptic turnover leads to increased accumulation of non-repaired molecular errors.
CONCLUSIONS
The weight-of-the-evidence presented in Tables  1-8 supports the hypothesis that the possession of the 4 allele in youth may have a positive differential impact on fitness during different life stages [145] . Young subjects having at least one copy of the 4 allele reportedly possess a number of advantages that might facilitate survival in harsh environments including the following among others: more rapid improvement in VO 2max following exercise [51] ; increased fertility at high pathogen burdens [52, 53] ; more rapid infant development [105] ; prophylaxis against cognitive deficits associated with severe diarrhea [122] [123] [124] ; resistance to certain infections, e.g., hepatitis [76] and malaria [83] ; faster reaction times [121] ; better spatial memory [111, 102, 119, 120] ; and slight superiority in direct or indirect measures of IQ [135, 134, 126, 141] . Some of these advantages appear to come at the expense of differences in neural processing that might place higher metabolic demands per unit time on the brains of young 4 carriers [143, 111, 96] .
Until 300,000 years ago, ancestors of modern humans were ubiquitously 4/4 and then the 3 allele mutated from the ancestral 4 allele [146] . The 3 allele displayed a competitive survival advantage sufficiently robust to result in the current predominance of the 3/3 genotype which is now found in over 60% of the US population, presumably because of its protection for memory loss and dementia in progressively older age ranges [23] . Similarly, the 2 allele mutated from the 3 allele about 200,000 years ago, but this protective allele has remained relatively rare with the homozygous 2/2 variant less than 1%, and the 3/2 heterozygote in about 11% of the population [144] .
Given the ancestral primacy of the 4 allele, and the evolutionary trade-off of superior performance in youth versus additional years beyond historical lifespans, the abnormality of the 4 allele is somewhat a matter of perspective. If part of the APOE 4-associated neurotoxic susceptibility is based on pharmacokinetic rather than toxicant receptor interactions on a per mole basis [20] , future therapies that slow down synaptic pruning might carefully consider differential effects based on APOE allele subtype. Current knowledge of potential sources of AD patient heterogeneity is lacking. Reducing at least one important source of inter-subject heterogeneity, i.e., APOE 4 allele carrier status, is advisable. Early attempts at shifting the balance away from synaptic pruning might consider enrolling early stage AD patients possessing at least one 4 allele.
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